Principal Financial Group Inc Ocugen, Inc. Transaction History

Principal Financial Group Inc

  • $1.66 Trillion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024
SELL
$0.98 - $1.95 $9,154 - $18,214
-9,341 Reduced 27.02%
25,225 $24,000
Q2 2024

Jul 29, 2024
SELL
$1.18 - $1.98 $29,249 - $49,080
-24,788 Reduced 41.76%
34,566 $53,000
Q1 2024

Apr 29, 2024
SELL
$0.5 - $1.83 $4,567 - $16,717
-9,135 Reduced 13.34%
59,354 $97,000
Q4 2023

Feb 07, 2024
BUY
$0.36 - $0.57 $2,422 - $3,834
6,728 Added 10.89%
68,489 $39,000
Q2 2023

Aug 07, 2023
BUY
$0.45 - $0.88 $491 - $960
1,092 Added 1.8%
61,761 $33,000
Q1 2023

May 09, 2023
SELL
$0.82 - $1.33 $3,662 - $5,941
-4,467 Reduced 6.86%
60,669 $51,000
Q4 2022

Feb 09, 2023
BUY
$1.11 - $1.87 $12,096 - $20,379
10,898 Added 20.09%
65,136 $84,000
Q3 2022

Nov 09, 2022
SELL
$1.75 - $3.1 $2,439 - $4,321
-1,394 Reduced 2.51%
54,238 $96,000
Q2 2022

Aug 10, 2022
SELL
$1.83 - $3.45 $1,268 - $2,390
-693 Reduced 1.23%
55,632 $126,000
Q1 2022

May 09, 2022
BUY
$2.34 - $4.72 $2,655 - $5,357
1,135 Added 2.06%
56,325 $186,000
Q4 2021

Feb 09, 2022
SELL
$4.38 - $15.67 $91,506 - $327,377
-20,892 Reduced 27.46%
55,190 $251,000
Q3 2021

Nov 09, 2021
BUY
$6.36 - $8.51 $19,964 - $26,712
3,139 Added 4.3%
76,082 $546,000
Q2 2021

Aug 10, 2021
BUY
$5.52 - $15.68 $402,645 - $1.14 Million
72,943 New
72,943 $585,000

Others Institutions Holding OCGN

# of Institutions
124
Shares Held
78.3M
Call Options Held
535K
Put Options Held
523K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $167M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email